Komori
Share Issuance and Disposal4891TMS Co.,Ltd.Pharmaceuticals

Notice Concerning the Monthly Exercise Status of the 10th Series of Stock Acquisition Rights (with Exercise Price Adjustment Provisions)

The exercise status of the 10th Stock Acquisition Rights for May 2026 was reported. No rights were exercised during the period, and no shares were delivered.

Worth reading
44Recurring
Scored from 1 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
0
Shares (number of shares delivered)
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Monthly report on the exercise status of stock acquisition rights with an exercise price adjustment clause

発行・処分する株式数

Shares delivered during the relevant month: 0 shares (0 new shares and 0 transferred treasury shares)

発行済株式総数

Exercise ratio during the month: 0% (ratio to the total number issued)

The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.

Terms of the stock acquisition rights
Exercise price
¥163.2 (as stated in the exercise status section for the relevant month). The floor under the adjustment clause was not disclosed
Number of Stock Acquisition Rights
Total issued: Not disclosed; unexercised as of the end of the month preceding the month covered: 28,700; unexercised as of the end of the month covered: 28,700
Most recent equity financing
31 March 2025: Issuance of the 10th Stock Acquisition Rights (with Exercise Price Adjustment Clause). Amount: Not disclosed
Details of issuance or disposal
ItemDetails
Type of issuance or disposalMonthly report on the exercise status of stock acquisition rights with an exercise price adjustment clause
Number of shares to be issued or disposed ofShares delivered during the relevant month: 0 shares (0 new shares and 0 transferred treasury shares)
Dilution RateExercise ratio during the month: 0% (ratio to the total number issued)
Total number of issued shares45,565,767 shares (as of the end of the month preceding the target month, including 10 treasury shares) → Not disclosed
Exercise price¥163.2 (as stated in the exercise status section for the relevant month). The floor under the adjustment clause was not disclosed
Number of Stock Acquisition RightsTotal issued: Not disclosed; unexercised as of the end of the month preceding the month covered: 28,700; unexercised as of the end of the month covered: 28,700
Most recent equity financing31 March 2025: Issuance of the 10th Stock Acquisition Rights (with Exercise Price Adjustment Clause). Amount: Not disclosed
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The company is reporting the monthly exercise status for May 2026 of the 10th Stock Acquisition Rights issued on 31 March 2025.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Concerning the Monthly Exercise Status of the 10th Series of Stock Acquisition Rights (with Exercise Price Adjustment Provisions) | TMS Co.,Ltd. (4891) timely disclosure | Komori